Literature DB >> 15148242

Water-soluble carbon monoxide-releasing molecules: helping to elucidate the vascular activity of the 'silent killer'.

Prabal Kumar Chatterjee1.   

Abstract

Carbon monoxide (CO) is formed during the degradation of haeme by haeme oxygenase (HO). As well as being an important signalling molecule and vasodilator, CO also possesses antihypertensive, anti-inflammatory and antiapoptotic qualities and protects against ischaemic tissue injury. Several approaches have been used to investigate the therapeutic potential of CO, ranging from direct administration of CO gas to the use of prodrugs, which generate CO upon metabolism. A novel approach involves the use of specific CO carriers, which will release measurable, controllable and effective amounts of CO into biological systems. Transitional metal carbonyls based around iron, manganese or ruthenium have recently been developed as CO-releasing molecules (CO-RMs) that, under appropriate conditions, will release CO. Such molecules have been shown to provide cardioprotection in both ex vivo and in vivo experiments. To date, CO-RMs have been largely incompatible with biological systems in that they are only soluble in organic solvents or have to be preactivated either by physical or chemical stimuli. However, the recent development of water-soluble CO-RMs has provided new opportunities to investigate the pharmacological and biological features of CO without such confounding influences. CORM-3, a novel water-soluble CO-RM, has recently been used to confirm the cardioprotective actions of CO. In this issue of British Journal of Pharmacology, Foresti and co-workers report that CORM-3 delivers CO, produces aortic vasodilation ex vivo and reduces blood pressure in vivo via modulation of the same cGMP and potassium channels utilised by endogenous and exogenous CO. These findings suggest that CORM-3 has the potential for use as a modulator of vascular function and hypertension. However, the use of water-soluble CO-RMs raises several questions of their own which will need to be addressed if CO-RMs are to be of future use therapeutically.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15148242      PMCID: PMC1574980          DOI: 10.1038/sj.bjp.0705826

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Inhaled CO: deadly gas or novel therapeutic?

Authors:  C Thiemermann
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  Synthesis and Structural Characterization of Several Ruthenium Porphyrin Nitrosyl Complexes.

Authors:  Katrina M. Miranda; Xianhui Bu; Ivan Lorkovic; Peter C. Ford
Journal:  Inorg Chem       Date:  1997-10-08       Impact factor: 5.165

Review 3.  Effects on health of prolonged exposure to low concentrations of carbon monoxide.

Authors:  C L Townsend; R L Maynard
Journal:  Occup Environ Med       Date:  2002-10       Impact factor: 4.402

Review 4.  Carbon monoxide -- a "new" gaseous modulator of gene expression.

Authors:  Józef Dulak; Alicja Józkowicz
Journal:  Acta Biochim Pol       Date:  2003       Impact factor: 2.149

5.  Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities.

Authors:  Roberto Motterlini; James E Clark; Roberta Foresti; Padmini Sarathchandra; Brian E Mann; Colin J Green
Journal:  Circ Res       Date:  2002-02-08       Impact factor: 17.367

6.  Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.

Authors:  James E Clark; Patrick Naughton; Sandra Shurey; Colin J Green; Tony R Johnson; Brian E Mann; Roberta Foresti; Roberto Motterlini
Journal:  Circ Res       Date:  2003-07-03       Impact factor: 17.367

7.  Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection.

Authors:  Christine Chauveau; Delphine Bouchet; Jean-Christian Roussel; Patrick Mathieu; Cécile Braudeau; Karine Renaudin; Laurent Tesson; Jean-Paul Soulillou; Suhasini Iyer; Roland Buelow; Ignacio Anegon
Journal:  Am J Transplant       Date:  2002-08       Impact factor: 8.086

Review 8.  Non-erythroid functions of erythropoietin.

Authors:  Max Gassmann; Katja Heinicke; Jorge Soliz; Omolara O Ogunshola
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

9.  Carbon monoxide: a putative neural messenger.

Authors:  A Verma; D J Hirsch; C E Glatt; G V Ronnett; S H Snyder
Journal:  Science       Date:  1993-01-15       Impact factor: 47.728

Review 10.  Therapeutic applications of human heme oxygenase gene transfer and gene therapy.

Authors:  Nader G Abraham
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

View more
  6 in total

Review 1.  Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities.

Authors:  Young-Myeong Kim; Hyun-Ock Pae; Jeong Euy Park; Yong Chul Lee; Je Moon Woo; Nam-Ho Kim; Yoon Kyung Choi; Bok-Soo Lee; So Ri Kim; Hun-Taeg Chung
Journal:  Antioxid Redox Signal       Date:  2010-10-26       Impact factor: 8.401

2.  Enhanced hemeoxygenase activity in the rostral ventrolateral medulla mediates exaggerated hemin-evoked hypotension in the spontaneously hypertensive rat.

Authors:  Noha N Nassar; Guichu Li; Aurel L Strat; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2011-07-18       Impact factor: 4.030

Review 3.  The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.

Authors:  Ioanna Andreadou; Efstathios K Iliodromitis; Tienush Rassaf; Rainer Schulz; Andreas Papapetropoulos; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-09-23       Impact factor: 8.739

4.  Physiological activities of carbon monoxide-releasing molecules: Ca ira.

Authors:  P K Chatterjee
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

Review 5.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

6.  Carbon monoxide-releasing molecule-3 protects against ischemic stroke by suppressing neuroinflammation and alleviating blood-brain barrier disruption.

Authors:  Jianping Wang; Di Zhang; Xiaojie Fu; Lie Yu; Zhengfang Lu; Yufeng Gao; Xianliang Liu; Jiang Man; Sijia Li; Nan Li; Xuemei Chen; Michael Hong; Qingwu Yang; Jian Wang
Journal:  J Neuroinflammation       Date:  2018-06-21       Impact factor: 8.322

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.